Compare ODC & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODC | QDEL |
|---|---|---|
| Founded | 1941 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 1994 | 2022 |
| Metric | ODC | QDEL |
|---|---|---|
| Price | $77.02 | $10.81 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 36.2K | ★ 2.9M |
| Earning Date | 06-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 50.45 | 45.35 |
| EPS | ★ 1.69 | N/A |
| Revenue | $485,572,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | $45.00 | ★ N/A |
| Revenue Growth | ★ 10.97 | N/A |
| 52 Week Low | $45.61 | $10.21 |
| 52 Week High | $76.76 | $35.58 |
| Indicator | ODC | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 69.18 | 34.51 |
| Support Level | $70.25 | N/A |
| Resistance Level | N/A | $17.78 |
| Average True Range (ATR) | 2.05 | 0.93 |
| MACD | 0.11 | 0.07 |
| Stochastic Oscillator | 93.02 | 18.14 |
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.